Navigating clinical trial operations in the era of collaboration
Running a successful clinical trial requires a combination of sector expertise, an eye towards emerging technologies and efforts to consider…
Running a successful clinical trial requires a combination of sector expertise, an eye towards emerging technologies and efforts to consider…
Rare disease clinical research is no longer an afterthought for pharmaceutical companies with rapid approvals and increased investment in this…
Last year, over half of the novel drugs approved by the US Food and Drug Administration (FDA) were orphan drugs,…
Regeneron Pharmaceuticals will sell potential Covid-19 prophylactic antibody at an internationally comparable price in the US to make it more…
Regeneron Pharmaceuticals will sell potential Covid-19 prophylactic antibody at an internationally comparable price in the US to make it more…
Nimbus Therapeutics has closed a $210m fundraising round involving existing and new investors, notably GV or Google Ventures. This comes…
This week, an influential US legislation designed to lower drug prices will provide the first glimpse of its possible impact…
Through a multi-year partnership harnessing its own expertise, and Tentatrix’s multifunctional biologics-driven platform, Gilead Sciences recently announced a play to…
As Eli Lilly gears up for releasing its Q2 earnings today, a key revenue and growth opportunity for the company—obesity…
Each week, Pharmaceutical Technology’s editors select a deal that illustrates the themes driving change in our sector. The deal may…